HALO logo
halo search icon
Voyager Therapeutics, Inc.

US$3.50

Price Change Indicator
0.02 (0.575%)
Voyager Therapeutics, Inc.
VYGR · NAS

Voyager Therapeutics, Inc.

Start Trading VYGR for Free

US$3.50

Price Arrow0.02 (0.575%)
20/05/2026 04:00:00 PM
All-CompaniesAll-ConsensusHALO AllHALO Consensus ValueHammer Bearish (Realtime)
Consensus Score
Lock Icon/10
Recommend
Lock
Target Price
Lock
Deviation
Lock
Unlock Full Consensus Insights

Voyager Therapeutics, Inc. Overview

VYGR Health Scores

Short Term

Mean Reversion

Neutral

Trend

Neutral

Event

Neutral

HALO Model

Mqv

Very Weak

Garp

Very Weak

Mqv Small

Neutral

Valuation

Value

Lock Icon

Consensus

Lock Icon

Momentum

Price

Very Weak

Earnings

Neutral

Growth

Earnings

Weak

Dividends

Very Weak

Quality

Capital Efficiency

Very Weak

Balance Sheet

Very Weak

About VYGR

icon
icon

Telephone

1.857.259.5340

icon

Address

75 Hayden Avenue, Lexington, MA 02421

Description

Voyager Therapeutics, Inc. is a clinical-stage gene therapy company, which engages in the development of treatments for severe neurological diseases. Its pipeline of gene therapy programs includes VY-AADC, VY-SOD101, VY-HTT01, VY-FXN01, Tau Program, and VY-NAV01. The company was founded by Guang Ping Gao, Mark A. Kay, Krystof Bankiewicz, and Phillip Zamore in June 2013 and is headquartered in Lexington, MA.

VYGR Price Chart

Key Stats

Market Cap

US$210.27M

PE

0.00

EV/EBITDA

N/A

Dividends Overview

DIV Yield

0%

Franking

0%

Ex Dividend Date (est.)

N/A

Market Data

52 weeks range

Low 2.64 - 5.55

Trade Value (12mth)

US$655,749.00

1 week

-7.57%

1 month

-15.53%

YTD

-13.65%

1 year

10.48%

All time high

31.91

Key Fundamentals

EPS 3 yr Growth

68.60%

EBITDA Margin

-316.50%

Operating Cashflow

-$132m

Free Cash Flow Return

-47.20%

ROIC

-42.70%

Interest Coverage

0.00

Quick Ratio

7.60

Other Data

Shares Outstanding (Fully Diluted)

59m

HALO Sector

Healthcare

Next Company Report Date

09-Mar-27

Next Ex Dividend Date

N/A

Next Dividend Pay Date

N/A

Reporting Currency

USD

Short Sell (% of issue)

0.00

VYGR Announcements

Latest Announcements

DateAnnouncements
08 May 26
08 May 26
08 May 26
08 May 26
08 May 26

VYGR Fundamentals

Per Share Records

Historical data

Forecast data

USD2021202220232024202320242025202620272028
Per Share, Growth & Valuations
EPS (Basic)
 $locklocklocklock3.08-1.13-2.04locklocklock
EPS (Fully Diluted)
 $locklocklocklock2.97-1.13-2.04locklocklock
Growth
 %locklocklocklock354.2-136.6-81locklocklock
PE
 Xlocklocklocklock2.8N/AN/Alocklocklock
EV/EBITDA
 Xlocklocklocklock1.7N/AN/Alocklocklock

Dividends

Key Stats

Ex Dividend Date (est.)

N/A

DIV Yield

0%

Franking Level

0%

DPSg

N/A

Quality Yield

lock

Falling Divs over next 2

lock

Want to learn more?Frequently asked questions.
What is the current share price of Voyager Therapeutics, Inc. (VYGR:NAS)?
Halo FAQ
The current share price of Voyager Therapeutics, Inc. (VYGR:NAS) is USD$3.50.
What is the 52-week high share price for Voyager Therapeutics, Inc. (VYGR:NAS)?
Halo FAQ
The 52-week high share price for Voyager Therapeutics, Inc. (VYGR:NAS) is USD$5.55.
What is the 52-week low share price for Voyager Therapeutics, Inc. (VYGR:NAS)?
Halo FAQ
The 52-week low share price for Voyager Therapeutics, Inc. (VYGR:NAS) is USD$2.64.
What is the dividend yield for Voyager Therapeutics, Inc. (VYGR:NAS)?
Halo FAQ
Voyager Therapeutics, Inc. (VYGR:NAS) does not pay a dividend.
What was Voyager Therapeutics, Inc. (VYGR:NAS) last dividend payment?
Halo FAQ
Voyager Therapeutics, Inc. (VYGR:NAS) does not pay a dividend.
What is the franking level for Voyager Therapeutics, Inc. (VYGR:NAS)?
Halo FAQ
Voyager Therapeutics, Inc. (VYGR:NAS) has a franking level of 0.00%.
In which sector is Voyager Therapeutics, Inc. (VYGR:NAS) classified?
Halo FAQ
Voyager Therapeutics, Inc. (VYGR:NAS) is classified in the Healthcare.

See beyond the curve.

One solution for research, investing and portfolio management.
Start FREE Trial